| Application no. and date | 22724712.9 (espacenet) (Federated) (European Patent Register), 20220422 | | Patent/reg. no. and date | DK/EP 4192882, 20250219 | | Publication date | 20230614 | | Priority no. and date | US 202163178745 P, 20210423, US 202163221986 P, 20210715, US 202163270091 P, 20211021 | | EP pub. no. and date |
EP 4192882 20230614 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | BB336104EPDK | | Inventor | SINIBALDI, Dominic,
Gaithersburg, Maryland 20878, US,
WHITE, Wendy,
Gaithersburg, Maryland 20878, US,
LINDHOLM, Catharina,
151 85 Södertälje, SE,
CHIA, Yen Lin,
Wilmington, Delaware 19850-5437, US,
TUMMALA, Rajendra,
Wilmington, Delaware 19850-5437, US,
ROSKOS, Lorin,
Gaithersburg, Maryland 20878, US,
ALMQUIST, Joachim,
151 85 Södertälje, SE,
ROUSE, Tomas,
151 85 Södertälje, SE,
TRASIEVA, Teodora,
151 85 Södertälje, SE,
RAMASWAMY, Madhu,
Gaithersburg, Maryland 20878, US,
NEWCOMBE, Paul,
Cambridge Cambridgeshire CB2 0AA, GB | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61M 5/00 (2006.01) , A61P 29/00 (2006.01) , C07K 16/28 (2006.01) , G01N 33/53 (2006.01) | | Title | BEHANDLING AF LUPUS NEPHRITIS MED ANTI-TYPE I INF-RECEPTOR-ANTISTOF ANIFROLUMAB | | Int. application no. | EP2022060670 | | Int. publication no. | WO2022223771 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
